In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
Japanese pharma company Otsuka has announced that its current vice chairman and representative director Ichiro Otsuka is now chairman and representative director. 30 March 2015
Biotechnology
Genome mapping specialist BioNano Genomics has appointed Terry Salyer as chief commercial officer. 26 March 2015
Pharmaceutical
Danish company Zealand Pharma is to make organizational and management changes, including splitting research and development divisions. 19 March 2015
Pharmaceutical
USA-based pharma company Inovio Pharmaceuticals has appointed Scott White as vice president of clinical development in infectious diseases. 18 March 2015
Pharmaceutical
Neurotech Pharmaceuticals has appointed Charles Johnson as chief medical officer. 18 March 2015
Pharmaceutical
Privately-held Swiss pharma company Polyphor has appointed Michael Altorfer as its new chief executive. 17 March 2015
Biotechnology
Moderna Therapeutics, a specialist in messenger RNA therapeutics, has appointed Tal Zaks as chief medical officer from March 16. 16 March 2015
Biotechnology
Shares of US biotech firm ACADIA Pharmaceuticals plunged 22% to 34.70 in after-hours trading, after it announced that it now plans to submit a New Drug application for Nuplazid (pimavanserin) for the treatment of Parkinson’s disease in the second half of 2015. 12 March 2015
Biotechnology
Privately-held genomics and biotech company 23andMe has created a new therapeutics group, and appointed Richard Scheller to lead it. 12 March 2015
Pharmaceutical
HUYA Bioscience International has appointed Alain Rolland as executive vice president and chief scientific officer. 12 March 2015
Pharmaceutical
US oncology and autoimmune biopharma company Lycera has appointed Jeffrey Wilkins to the newly-created chief medical officer position. 9 March 2015
Biotechnology
French biotech company Adocia has created a US subsidiary, Adocia Incorporated, and appointed Simon Bruce and Stephen Daly. 6 March 2015
Pharmaceutical
Taiwanese pharma company Twi Pharmaceuticals has appointed Tina Guilder as president and chief executive officer. 5 March 2015
Pharmaceutical
Pharma industry sales force levels in 2014 showed a slowdown in the decline seen in previous years, according to market research company Cegedim Strategic Data (CSD). 5 March 2015
Pharmaceutical
Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease, has appointed Rafael Amado as chief medical officer and Adrian Rawcliffe as chief financial officer. 4 March 2015
Pharmaceutical
Canadian cannabinoid therapy specialist InMed Pharmaceuticals has appointed Ado Mohammed as chief medical officer. 4 March 2015
article
French drug maker Ipsen has appointed Dominique Laymand as senior vice president, chief ethics and compliance officer for the group. 4 March 2015
Pharmaceutical
Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer. 4 March 2015
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has promoted Christophe Weber from representative director, president and chief operating officer to representative director, president and chief executive officer. 4 March 2015
Biotechnology
Jeffrey Barrett has been appointed the founding director for the Centre for Therapeutic Target Validation, a public-private partnership between GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute. 2 March 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze